NVST icon

Envista

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 23.8%
Negative

Positive
Zacks Investment Research
15 days ago
Why Envista (NVST) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Envista (NVST) is a Top Value Stock for the Long-Term
Neutral
24/7 Wall Street
17 days ago
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets.
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
Positive
MarketBeat
17 days ago
Envista Q1 Earnings Call Highlights
Envista NYSE: NVST reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
Envista Q1 Earnings Call Highlights
Neutral
Zacks Investment Research
19 days ago
Envista (NVST) International Revenue Performance Explored
Explore Envista's (NVST) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Envista (NVST) International Revenue Performance Explored
Positive
Zacks Investment Research
22 days ago
Why Envista (NVST) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Envista (NVST) is a Top Growth Stock for the Long-Term
Positive
Seeking Alpha
23 days ago
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
My existing 'buy' rating for Envista is left unchanged following my evaluation of its results and outlook. NVST's 1Q2026 earnings beat consensus by 15%, thanks to a defensive dental market and the company's own cost reduction efforts. The company's high-teens EPS growth guidance for the full year is well-supported by new product launches and synergies relating to its latest M&A.
Envista: Spotlight On Q1 Outperformance And New Growth Drivers
Neutral
Seeking Alpha
23 days ago
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Envista Holdings Corporation (NVST) Q1 2026 Earnings Call Transcript
Positive
Zacks Investment Research
23 days ago
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
Positive
Zacks Investment Research
23 days ago
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.24 per share a year ago.
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Neutral
PRNewsWire
24 days ago
Envista Reports First Quarter 2026 Results
BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
Envista Reports First Quarter 2026 Results